Finasteride inhibits melanogenesis through regulation of the adenylate cyclase in melanocytes and melanoma cells
暂无分享,去创建一个
S. Kim | S. Yumnam | Kwang Won Jeong | J. Seo
[1] N. Giribabu,et al. Testosterone regulates levels of cystic fibrosis transmembrane regulator, adenylate cyclase, and cAMP in the seminal vesicles of orchidectomized rats. , 2016, Theriogenology.
[2] G. Merlino,et al. A melanin‐independent interaction between Mc1r and Met signaling pathways is required for HGF‐dependent melanoma , 2015, International journal of cancer.
[3] D. Rousso,et al. A review of medical and surgical treatment options for androgenetic alopecia. , 2014, JAMA facial plastic surgery.
[4] T. Ząbkowski. Evaluation of the clinical indications, adverse drug reactions, and finasteride use in patients with benign prostatic hyperplasia in Poland , 2014, Pharmacological reports : PR.
[5] Aditya K. Gupta,et al. The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit–risk assessment of finasteride and dutasteride , 2014, The Journal of dermatological treatment.
[6] J. Baek,et al. Inhibitory Effect of Corn Silk on Skin Pigmentation , 2014, Molecules.
[7] S. Kim,et al. Inhibitory Effects of Resveratrol on Melanin Synthesis in Ultraviolet B-Induced Pigmentation in Guinea Pig Skin , 2014, Biomolecules & therapeutics.
[8] K. Dutton-Regester,et al. MC1R is a potent regulator of PTEN after UV exposure in melanocytes. , 2013, Molecular cell.
[9] F. McCormick,et al. MC1R and cAMP signaling inhibit cdc25B activity and delay cell cycle progression in melanoma cells , 2013, Proceedings of the National Academy of Sciences.
[10] D. Albanes,et al. Pigmentation-related phenotypes and risk of prostate cancer , 2013, British Journal of Cancer.
[11] Piul S. Rabbani,et al. Direct migration of follicular melanocyte stem cells to the epidermis after wounding or UVB irradiation is dependent on Mc1r signaling , 2013, Nature Medicine.
[12] Jochen K. Lennerz,et al. A UV-independent pathway to melanoma carcinogenesis in the redhair-fairskin background , 2012, Nature.
[13] V. Swope,et al. Alpha-Melanocyte–Stimulating Hormone Suppresses Oxidative Stress through a p53-Mediated Signaling Pathway in Human Melanocytes , 2012, Molecular Cancer Research.
[14] A. Slominski,et al. L‐tyrosine and L‐dihydroxyphenylalanine as hormone‐like regulators of melanocyte functions , 2012, Pigment cell & melanoma research.
[15] T. Vogt,et al. Reciprocal responses of fibroblasts and melanocytes to α-MSH depending on MC1R polymorphisms , 2011, Dermato-endocrinology.
[16] A. Stratigos,et al. Melanocortin 1 Receptor Variants: Functional Role and Pigmentary Associations , 2011, Photochemistry and photobiology.
[17] Jeong-Chae Lee,et al. Quercetin Inhibits α‐MSH‐stimulated Melanogenesis in B16F10 Melanoma Cells , 2011, Phytotherapy research : PTR.
[18] Eunjung Moon,et al. Inhibitory effects of 1,3‐thiazine derivatives on melanogenesis , 2009 .
[19] F. Schröder,et al. Key targets of hormonal treatment of prostate cancer. Part 2: the androgen receptor and 5α‐reductase , 2009, BJU international.
[20] R. Sturm,et al. Post-transcriptional regulation of melanin biosynthetic enzymes by cAMP and resveratrol in human melanocytes. , 2007, The Journal of investigative dermatology.
[21] D. Fisher,et al. Melanocyte biology and skin pigmentation , 2007, Nature.
[22] M. Ford,et al. A new look at the 5alpha-reductase inhibitor finasteride. , 2006, CNS drug reviews.
[23] J. García-Borrón,et al. Melanocortin-1 receptor structure and functional regulation. , 2005, Pigment cell research.
[24] D. Tobin,et al. Melanin pigmentation in mammalian skin and its hormonal regulation. , 2004, Physiological reviews.
[25] R C Bruskewitz,et al. The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. , 2002, The New England journal of medicine.
[26] R. Willemze,et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. , 2001, The Journal of investigative dermatology.
[27] J. Simard,et al. Local and systemic reduction by topical finasteride or flutamide of hamster flank organ size and enzyme activity. , 1995, The Journal of investigative dermatology.
[28] R. Mason,et al. Effects of estrogens on human melanocytes in vitro , 1994, The Journal of Steroid Biochemistry and Molecular Biology.
[29] J. Nadeau,et al. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function , 1993, Cell.
[30] G. Andriole,et al. The effect of finasteride in men with benign prostatic hyperplasia. , 1992, The Journal of urology.
[31] M. Mortrud,et al. The cloning of a family of genes that encode the melanocortin receptors. , 1992, Science.
[32] I. Jackson,et al. A second tyrosinase‐related protein, TRP‐2, is a melanogenic enzyme termed DOPAchrome tautomerase. , 1992, The EMBO journal.
[33] J. Pawelek,et al. UVB-induced melanogenesis may be mediated through the MSH-receptor system. , 1989, The Journal of investigative dermatology.
[34] T. Kuroki,et al. Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid. , 1985, Cancer research.
[35] S. Pomerantz,et al. Regulation of tyrosinase in human melanocytes grown in culture , 1983, The Journal of cell biology.
[36] R. Snell,et al. The effect of testosterone on the melanocytes and melanin in the skin of the intact and orchidectomised male guinea-pig. , 1959, The Journal of investigative dermatology.
[37] L. Timares,et al. MC1R, Eumelanin and Pheomelanin: Their Role in Determining the Susceptibility to Skin Cancer , 2015, Photochemistry and photobiology.
[38] Jochen K. Lennerz,et al. An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair / fair skin background , 2012 .
[39] J. Geller,et al. Castration-like effects on the human prostate of a 5 alpha-reductase inhibitor, finasteride. , 1992, Journal of cellular biochemistry. Supplement.
[40] J. Geller,et al. Castration‐like effects on the human prostate of a 5α‐reductase inhibitor, finasteride , 1992 .